@article{Putra_Santoso_2020, title={Cardiovascular Disease and COVID-19: What’s the Issue?}, volume={70}, url={https://mki-ojs.idijawatimur.org/jurnal/article/view/231}, DOI={10.47830/jinma-vol.70.4-2020-231}, abstractNote={What’s our status? As per 17 April 2020, Indonesia has the most confirmed cases (5.923 cases) of Coronavirus Disease (COVID-19) among Southeast Asian Countries.<a href="https://paperpile.com/c/h04Qca/tc8u">1</a> Considering the daily increase of cases, we are considered nowhere near the plateau of the epidemic curve. It was predicted that the peak may be reached from May to June.<a href="https://paperpile.com/c/h04Qca/CrSU">2</a> Predictably, this will not end soon. COVID-19 contracted patients may also vary in severity. The patient may present with no symptoms, mild to moderate, and severe condition. Mild (81%) depicted as COVID-19 patients with no evidence or mild pneumonia, severe (14%) for COVID-19 patients with hypoxia and greater than 50% lung involvement within 24-48 hours, critical (5%) if the patient develops shock, acute respiratory distress syndrome, myocarditis, or even organ failure which need intensive care, and 2.3 % were fatal which end up in death.<a href="https://paperpile.com/c/h04Qca/ye5q+95KG">3,4</a>}, number={4}, journal={Majalah Kedokteran Indonesia}, author={Putra, Bayushi Eka and Santoso, Anwar}, year={2020}, month={Mei}, pages={38-40} }